Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN70,5470,561,74
Msft-0,19
Nokia3,59353,610,43
IBM0,04
Mercedes-Benz Group AG68,1268,14-0,38
PFE-0,97
18.05.2024 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 17.05.2024 18:00:32
Krka DD (KRK.WA, Warsaw)
Závěr k 17.5.2024 Změna (%) Změna (PLN) Objem obchodů (PLN)
544,00 0,00 0,00 38 700
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 18.05.2024
Popis společnosti
Obecné informace
Název společnostiKrka d.d. Novo Mesto
TickerKRKG
Kmenové akcie:Ordinary Shares
RICKRKG.LJ
ISINSI0031102120
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.03.2024
Počet zaměstnanců k 31.03.2024 11 795
Akcie v oběhu k 31.03.2024 30 822 848
MěnaEUR
Kontaktní informace
UliceSmarjeska cesta 6
MěstoNOVO MESTO
PSČ8501
ZeměSlovenia
Kontatní osoba 
Funkce kontaktní osoby 
Telefon38 673 312 111
Fax38673321537

Business Summary: Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Financial Summary: BRIEF: For the three months ended 31 March 2024, Krka d.d. Novo Mesto revenues increased 6% to EUR486.1M. Net income increased 11% to EUR98.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Net foreign exchange differences decrease of 97% to EUR350K (expense), Whereof net impairments and write-offs o decrease from EUR1.3M (expense) to EUR214K (income).
Odvětvová klasifikace
TRBC2012Generic Pharmaceuticals
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSMedicinal and Botanical Manufacturing
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Medicinal & Botanical Mfg
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Medicinal and Botanical Manufacturing
SICPharmaceutical Preparations
SICMedicinals And Botanicals



  • Poslední aktualizace: 18.05.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman (President) of the Supervisory Board - Shareholders' RepresentativeJoze Mermal7027.07.201621.06.2015
Chief Executive Officer, Chairman (President) of the Management BoardJoze Colaric6801.01.200501.01.1993
Independent Vice Chairman (Deputy President) of the Supervisory Board - Shareholders' RepresentativeMatej Lahovnik5301.01.2020
Independent Vice Chairman (Deputy President) of the Supervisory Board - Employees' RepresentativeFranc Sasek5721.06.200921.06.2009
Member of the Management BoardDavid Bratoz4818.11.201518.11.2015
Member of the Management Board - Worker Director, Deputy Director of Pharmaceutical ProductionMilena Kastelic5628.09.2015
Member of the Management Board, Director of Pharmaceutical R&D and ProductionAles Rotar6301.01.2001
Member of the Management Board, Director of API R&D, Production and Supply ChainVinko Zupancic5201.01.201001.01.2010